For individuals prescribed GLP-1 receptor agonists as part of a comprehensive diabetes or obesity management plan, incorporating allulose as a sugar substitute could support treatment goals without compromising palatability
The pill is also approved to help reduce the risk of serious cardiovascular events like nonfatal heart attacks and strokes
[1] When patients take GLP-1 receptor agonists, healthcare providers typically monitor several blood parameters to assess treatment efficacy and safety, though none of these tests directly measure the GLP-1 medication itself
10.1016/j.tins.2017.04.002 Trends Neurosci
Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, Dai Li, Grubert F et al (2009) The Genetic Architecture of Down Syndrome Phenotypes Revealed by High-Resolution Analysis of Human Segmental Trisomies